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W-AM-SymII-l
NEW MECHANISM OF REGULATION OF K+-Cl- COTRANSPORT. ((N.C.
Adragna, H. Ahmed, C.M. Ferrell, J. Filosa and P.K. Lauf)) Wright State
University, Dayton, OH 45435.
Nitrovasodilators, through a cGMP-dependent pathway involving the inositol
phosphate (IP) cycle decrease intracellular Ca + and induce vasodilation b
activation of ion channels. K+-Cl- cotransport (COT) promotes the electroneutral-
coupled movement of K+ and Cl- ions and plays an important role in regulatory
volume decrease. K+-CI- COT is activated by cell swefling, thiol (SH) reagents,
and by lowering cellular Mg++and H+concentrations. Our recent findings indicate
that Li regulates K+-Cl- COT with involvement of the IP cycle and that in low K
sheep red blood cells (LK SRBCs), nitrite (a nitric oxide derivative) and other
vasodilators stimulate the transporter from two- to 10-fold. To test our hypothesis
whereby a new mechanism of regulation of K+-Cl- COT involves the cGMP-
dependent pathway, we further characterized the effect of the vasodilators studied
both in LK SRBCs and in cultured vascular smooth muscle cells (CVSMCs). K+-
Cl- COT was measured at different osmolalities, drug concentrations and in the
presence of inhibitors of other pathways for K(Rb) transport. Hydralazine
stimulated K-Cl COT by 5-fold in LK SRBCs and by 20-folci in CVSMCs, and
was the most potent activator in LK SRBCs where it decreased glutathione by
100%. Protein/threonine phosphatase I and tyrosine kinase regulate K+-Cl- COT
via a metabolic cascade. Inhibition of the phosphatase and kinase by calyculin
and genistein, respectively, suggest an upstream site for the action of hydralazine
and isosorbide mononitrate. Further testing of our hypothesis include the study
of specific activators and inhibitors of the cGMP pathway on K+-Cl- COT
activity. Our findings suggest a role for K+-Cl- COT in vasodilation. (Supported
by NIH, NAHA, AHAOH and the WSU BMS Program)
W-AM-SymII-3
HOW OUABAIN WORKS: KEY ROLE OF THE PLASMEROSOME IN THE
REGULATION OF CELL RESPONSIVENESS. ((M.P. Blaustein, A. Arnon,
J.M. Hamlyn and M. Juhaszova)) Physiol. Dept., Univ. Maryland Med. Sch.,
Baltimore, MD 21201
Cardiotonic steroids are believed to amplify cell activity by inhibiting Na+
pumps and elevating cytosolic Na+ ([Na+]cyT). Na+ pump catalytic subunit
(a) isoforms with different affinities for ouabain and Na+ distribute differently
in the plasmalemma (PL) of rat astrocytes, neurons, and arterial myocytes.
The low ouabain affinity (IC50 >10,000 nM), high Na+ affinity (Kd 12 mM)
isoform (al) is ubiquitously distributed in the PL, but high ouabain affinity
(IC50< 50 nM), low Na+ affinity (Kd's = 24-33 mM) isoforms (a2 and a3) are
confined to PL domains overlying sarcoplasmic/endoplasmic reticulum
(S/ER). This implies that the different isoforms have distinct functions. The
junctional S/ER and adjacent PL form a functional unit ("PLasmERosome")
containing z10-12_10-13 liters cytosol. We tested 10-100 nM ouabain on
evoked Ca2+ (Fura-2) transients in rat artery myocytes. Transients evoked
by 30 s of 5-HT, AVP, or S/ER Ca2+ pump inhibitors, were augmented by
30-120 s exposure to ouabain, human ouabain-like compound, or 1 mM K+;
'bulk" resting [Na+]cyT (SBFI) and [Ca2+]cYT were not elevated. Augmenta-
tion required external Na+ but not Ca2+; removal of external Na+ for 120 s
augmented evoked Ca2+ transients in the absence of ouabain. Conclusion:
a2/a3 Na+ pumps control PLasmERosome [Na+]cy; this, in turn, regulates,
via Na+/Ca2+ exchange, local [Ca2+]cYT. Ca2+ signaling and cell responses.
W-AM-SymIl-2
NEW METABOLIC PATHWAYS IN THE REGULATION OF THE
SQUID Na/Ca EXCHANGE.
R. DiPolou#and L. Beauge* * #. *IVIC, Caracas, Venezuela. -"Instituto M. y M.
Ferreira, C6rdoba, Argentina. #Marine Biological Lab. Woods Hole, MA, USA.
Metabolic up-regulation of the Na/Ca exchanger by ATP transforms and ineffi-
cient carrier into a highly efficient one by increasing the affinities for Cat and Na,.
The mechanism for ATP regulation is different among species and even for different
tissues of the same species. Nevertheless, a common property is that a phospho-
rylation dephosphorylation process is involved. Three steps will be considered:
i)the pathway for phosphoryl group transfer: a protein or a lipid kinase (s). ii)
the target for phosphorylation: the exchanger or other regulatory molecule/s, and
iii) the dephosphorylation process. For the squid Na/Ca exchanger the data show:
1)ATP modulation does not involve the classical protein kinases (PKA, PKC,
PtyrK, CAM-PK). 2) a soluble 13 kDa cytosolic regulatory protein (a novel pro-
tein) is required, 3)deactivation of the Na/Ca exchanger by removal of ATP occurs
through a Mg2+i-dependent process, and 4) phosphoinositides are not involved.
Finally, we will present evidences for a novel metabolic pathway of regulation
of the squid exchanger by phosphoarginine. (CONICIT Si-97001675; CONICET
4904/97, FONCYT 05-00000-01092/97, NSF IBN-9631107).
W-AM-SymII-4
Ca/H EXCHANGE VIA THE PLASMA MEMBRANE Ca ATPase
IN SKELETAL MUSCLE
R. Duque, C. Wiseman, J.DeSantiago, D.Batlle, M. Khilnani, S.Dedhia, J. Kul-
czyk, C. Penia-Rasgado & H. Rasgado-Flores. FUHS/Chicago Med. Sch. N.
Chicago, IL 60064
The aims of this work were to determine: 1) whether Ca exit via the plasma mem-
brane Ca ATPase is coupled to H entry (Ca/H exchange); 2) whether operation of
the Ca ATPase has an absolute requirement on external H; 3) the stoichiometry of
the Ca/H exchange; and 4) whether the Ca/H exchange is voltage-sensitive. The
internally-perfused, voltage-clamped barnacle muscle cell was used as a model.
The results indicate the following: i) Ca efflux is dependent on external pH, is
accompanied by a membrane depolarization and an intracellular acidification that
is greater than that expected from Ho "leak" and ATP hydrolysis; ii) Ca efflux is
inhibited in the presence of various plasma membrane Ca ATPase blockers and by
ATP depletion, indicating that a plasma membrane Ca ATPase mediates Ca/H
exchange; iii) Ca/H exchange is not absolutely required for operation of the plasma
membrane Ca-ATPase; iv) Ca/H exchange is voltage-sensitive being activated by
depolarization; and v) the coupling ratio of the Ca/H exchange varies depending
on the availability of Ho. At an acidic pHo (6.5), the plasma membrane Ca AT-
Pase mediates a fast Ca/H exchange with a coupling ratio of 3-4 H: 1 Ca whereas
at an alkaline pHo (8.2), it operates slowly with a likely coupling ratio of 0 H/lCa.
It is proposed that the plasma membrane Ca ATPase mediates a voltage-sensitive
Ca/H exchange with a variable stoichiometry
W-AM-SymlI-5
THE THYROID IODIDE TRANSPORTER: THE EMERGING
MOLECULAR PICTURE
O Levy, A De la Vieja, C Ginter, C Riedel, G Dai & N Carrasco. Albert Einstein
College of Medicine, NY 10461
The Na+/I- symporter (NIS), a 618 amino acid membrane glycoprotein that
mediates the active accumulation of I- into thyroid cells, has been identified,
characterized at the molecular level in our laboratory, and analyzed electrophysio-
logically. We have substituted both separately and simultaneously the asparagine
residues in all three putative N-linked glycosylation consensus sequences of NIS
with glutamine, and assessed the effects of the mutations on function and stability
of NIS in COS cells. All mutants were active and displayed 50-90% of wild-
type NIS activity, including the completely non-glycosylated triple mutant. This
demonstrates that function and stability of NIS are preserved in the absence of
N-linked glycosylation. We also found that N225 is glycosylated, thus proving that
the hydrophilic loop that contains this amino acid residue faces the extracellular
milieu. We demonstrated that the NH2 terminus faces extracellularly as well. A
new secondary structure model consistent with these findings has been proposed.
Patients with congenital lack of I- transport do not accumulate I- in their thy-
roids, often resulting in severe hypothyroidism. A single amino acid substitution
in NIS, proline replacing threonine at position 354 (T354P), was recently identified
as the cause of this condition in several independent patients. Here we report that
in T354P NIS the lack of I- transport activity is not due to a structural change
induced by proline, but rather to the absence of a hydroxyl group at the b carbon
at position 354. Hence, this hydroxyl group is essential for NIS function
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